Shopping Cart
Remove All
Your shopping cart is currently empty
LW106
Catalog No. T213367 Copy Product Info
🥰Excellent
LW106 is a selective IDO1 inhibitor with an IC50 of 1.57 μM. It does not inhibit IDO2 and TDO. LW106 suppresses tumor growth by limiting substrate immune crosstalk and enriching cancer stem cells (CSC) within the tumor microenvironment. It reduces CSC subpopulations in xenograft tumors, leading to decreased tumor cell proliferation/invasiveness and inducing apoptosis. LW106 is applicable in research on lung cancer and melanoma.
LW106
Copy Product Info🥰Excellent
Catalog No. T213367
LW106 is a selective IDO1 inhibitor with an IC50 of 1.57 μM. It does not inhibit IDO2 and TDO. LW106 suppresses tumor growth by limiting substrate immune crosstalk and enriching cancer stem cells (CSC) within the tumor microenvironment. It reduces CSC subpopulations in xenograft tumors, leading to decreased tumor cell proliferation/invasiveness and inducing apoptosis. LW106 is applicable in research on lung cancer and melanoma.
LW106
Cas No. 2116519-76-5
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | LW106 is a selective IDO1 inhibitor with an IC50 of 1.57 μM. It does not inhibit IDO2 and TDO. LW106 suppresses tumor growth by limiting substrate immune crosstalk and enriching cancer stem cells (CSC) within the tumor microenvironment. It reduces CSC subpopulations in xenograft tumors, leading to decreased tumor cell proliferation/invasiveness and inducing apoptosis. LW106 is applicable in research on lung cancer and melanoma. |
| Targets&IC50 | IDO1:1.57 μM |
| In vitro | LW106 (12.5-200 μM) does not affect the proliferation of three tumor cell lines with different IDO1 expression levels (HeLa, Lewis, and B16F10 cells). It restores CD8+ T cell function by inhibiting the activity of IDO1. |
| In vivo | LW106, administered via intraperitoneal injection at dosages of 20-80 mg/kg once daily for 18 consecutive days, is effective in inhibiting the growth of Lewis lung carcinoma or B16F10 melanoma tumors. Its antitumor effect relies on T cell immunity and host-derived IDO1. |
| Molecular Weight | 245.24 |
| Formula | C11H11N5O2 |
| Cas No. | 2116519-76-5 |
| Smiles | ON=C(C1=NON=C1N)N2CC=3C=CC=CC3C2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Citations
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy LW106 | purchase LW106 | LW106 cost | order LW106 | LW106 in vivo | LW106 in vitro | LW106 formula | LW106 molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.